Retour
Novo Nordisk A/S (NVO) Gagner
Graphique du cours de l'action NVO
NVO Gagner
Novo Nordisk A/S
$36.34
-1.49%
$-0.54
À la fermeture : Mar 25, 16:00:00 GMT-4
$36.5
0.44%
$0.15
Post-Marché: Mar 25, 20:00:00 GMT-4
Statistiques clés
Clôture préc.
$36.89
Prix d'ouverture
$37.15
Plage de la journée
$36.23 - $37.39
Plage de 52 semaines
$35.85 - $81.44
Volume
14.3M
Volume moyen
24.2M
Rendement en dividend
--
BPA (TTM)
3.64
Capitalisation boursière
$123.0B
Qu’est-ce que Novo Nordisk A/S ?
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The firm's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The firm's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The firm also offers Saxenda product to treat obesity. The company offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.